Ourania Tatsis - Net Worth and Insider Trading
Ourania Tatsis Net Worth
The estimated net worth of Ourania Tatsis is at least $24 Million dollars as of 2024-11-05. Ourania Tatsis is the EVP, Chief Reg. & Quality Off. of Vertex Pharmaceuticals Inc and owns about 49,098 shares of Vertex Pharmaceuticals Inc (VRTX) stock worth over $24 Million. Details can be seen in Ourania Tatsis's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ourania Tatsis has not made any transactions after 2024-06-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ourania Tatsis
Ourania Tatsis Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ourania Tatsis owns 1 companies in total, including Vertex Pharmaceuticals Inc (VRTX) .
Click here to see the complete history of Ourania Tatsis’s form 4 insider trades.
Insider Ownership Summary of Ourania Tatsis
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| VRTX | Vertex Pharmaceuticals Inc | 2024-06-03 | EVP & Chief Reg. & Quality Off. |
Ourania Tatsis Latest Holdings Summary
Ourania Tatsis currently owns a total of 1 stock. Ourania Tatsis owns 49,098 shares of Vertex Pharmaceuticals Inc (VRTX) as of June 3, 2024, with a value of $24 Million.
Latest Holdings of Ourania Tatsis
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VRTX | Vertex Pharmaceuticals Inc | 2024-06-03 | 49,098 | 486.53 | 23,887,650 |
Holding Weightings of Ourania Tatsis
Ourania Tatsis Form 4 Trading Tracker
According to the SEC Form 4 filings, Ourania Tatsis has made a total of 25 transactions in Vertex Pharmaceuticals Inc (VRTX) over the past 5 years, including 0 buys and 25 sells. The most-recent trade in Vertex Pharmaceuticals Inc is the sale of 2,175 shares on June 3, 2024, which brought Ourania Tatsis around $1 Million.
Insider Trading History of Ourania Tatsis
- 1
Ourania Tatsis Trading Performance
Ourania Tatsis Ownership Network
Ownership Network List of Ourania Tatsis
Ownership Network Relation of Ourania Tatsis
Ourania Tatsis Owned Company Details
What does Vertex Pharmaceuticals Inc do?
Who are the key executives at Vertex Pharmaceuticals Inc?
Ourania Tatsis is the EVP & Chief Reg. & Quality Off. of Vertex Pharmaceuticals Inc. Other key executives at Vertex Pharmaceuticals Inc include EVP and Chief Legal Officer Jonathan Biller , EVP and CMO Carmen Bozic , and director & CEO & President Reshma Kewalramani .
Vertex Pharmaceuticals Inc (VRTX) Insider Trades Summary
Over the past 18 months, Ourania Tatsis made 8 insider transaction in Vertex Pharmaceuticals Inc (VRTX) with a net sale of 16,533. Other recent insider transactions involving Vertex Pharmaceuticals Inc (VRTX) include a net sale of 47,585 shares made by Carmen Bozic , a net sale of 77,232 shares made by Reshma Kewalramani , and a net sale of 51,156 shares made by Jeffrey M Leiden .
In summary, during the past 3 months, insiders sold 9,001 shares of Vertex Pharmaceuticals Inc (VRTX) in total and bought 0 shares, with a net sale of 9,001 shares. During the past 18 months, 345,317 shares of Vertex Pharmaceuticals Inc (VRTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 345,317 shares.
Vertex Pharmaceuticals Inc (VRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Vertex Pharmaceuticals Inc Insider Transactions
Ourania Tatsis Mailing Address
Above is the net worth, insider trading, and ownership report for Ourania Tatsis. You might contact Ourania Tatsis via mailing address: C/o Vertex Pharmaceuticals, Inc., 50 Northern Avenue, Boston Ma 02210.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
